Fortis Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Fortis Capital Advisors's BMY Position: Q2 2026 in Review
Fortis Capital Advisors increased its Bristol-Myers Squibb (BMY) stake by 15% in Q2 2026, buying an estimated $101K and bringing the position to 13,795 shares worth $795K. The position accounts for 0.09% of the portfolio, ranked #191.
Fortis Capital Advisors first reported a position in BMY in Q4 2022 and has held it in 6 quarters since. The position peaked at $1.21M in Q1 2025. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Fortis Capital Advisors held 13,795 shares of Bristol-Myers Squibb worth $795K as of Q2 2026.
- Fortis Capital Advisors bought 1,753 Bristol-Myers Squibb shares in Q2 2026, an estimated $101K.
- Bristol-Myers Squibb made up 0.09% of Fortis Capital Advisors's portfolio in Q2 2026, its #191 holding.
- Fortis Capital Advisors first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 6 quarters since.
- Fortis Capital Advisors's Bristol-Myers Squibb position peaked at $1.21M in Q1 2025.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Fortis Capital Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.